标题
Vinflunine for the treatment of breast cancer
作者
关键词
-
出版物
EXPERT OPINION ON PHARMACOTHERAPY
Volume 17, Issue 13, Pages 1817-1823
出版商
Informa UK Limited
发表日期
2016-08-03
DOI
10.1080/14656566.2016.1217991
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cytotoxic chemotherapy: Still the mainstay of clinical practice for all subtypes metastatic breast cancer
- (2016) Chris Twelves et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
- (2016) Massimo Cristofanilli et al. LANCET ONCOLOGY
- 5P * MICROTUBULE-DEPOLYMERIZING AGENTS USED IN ANTIBODY-DRUG-CONJUGATES INDUCE ANTITUMOR ACTIVITY BY STIMULATION OF DENDRITIC CELLS
- (2014) K. Martin et al. ANNALS OF ONCOLOGY
- A phase I clinical and pharmacokinetic study evaluating vinflunine in combination with epirubicin as first-line treatment in metastatic breast cancer
- (2014) S. Chan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase II study of intravenous vinflunine after failure of first-line vinorelbine based regimen for advanced breast cancer
- (2012) Maria Blasinska-Morawiec et al. BREAST
- A phase 1 study of vinflunine in combination with trastuzumab for the treatment for HER2-positive metastatic breast cancer
- (2012) R. Paridaens et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancer
- (2011) K. Zaman et al. BREAST CANCER RESEARCH AND TREATMENT
- A phase I study of vinflunine in combination with capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes
- (2011) M. Campone et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
- (2011) Javier Cortes et al. LANCET
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase II Trial of Vinflunine As Monotherapy or in Combination with Trastuzumab as First-Line Treatment of Metastatic Breast Cancer
- (2010) Denise A. Yardley et al. CANCER INVESTIGATION
- A phase I evaluation of the combination of vinflunine and erlotinib in patients with refractory solid tumors
- (2010) Hanna K. Sanoff et al. INVESTIGATIONAL NEW DRUGS
- Phase 2 Study of Single-Agent IV Vinflunine as Third-Line Treatment of Metastatic Breast Cancer After Failure of Anthracycline-/Taxane-Based Chemotherapy
- (2009) Pierre Fumoleau et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Phase III Trial of Vinflunine Plus Best Supportive Care Compared With Best Supportive Care Alone After a Platinum-Containing Regimen in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract
- (2009) Joaquim Bellmunt et al. JOURNAL OF CLINICAL ONCOLOGY
- Vinflunine: A New Microtubule Inhibitor Agent
- (2008) J. Bennouna et al. CLINICAL CANCER RESEARCH
- Residual Risk of Breast Cancer Recurrence 5 Years After Adjuvant Therapy
- (2008) A. M. Brewster et al. JNCI-Journal of the National Cancer Institute
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started